Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
Yoshikazu TakahashiYu SunakawaEisuke InoueRyohei KawabataAtsushi IshiguroYosuke KitoYusuke AkamaruMasazumi TakahashiHiroshi YabusakiJin MatsuyamaAkitaka MakiyamaMasahiro TsudaTakahisa SuzukiHisateru YasuiRyo MatobaHisato KawakamiTakako Eguchi NakajimaKei MuroWataru IchikawaMasashi FujiiPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)
Our real-world data demonstrated the comparable survival time to a previous clinical trial and revealed the frequency and prognosis of patients with HPD in advanced GC treated with nivolumab.
Keyphrases
- clinical trial
- phase ii
- study protocol
- phase iii
- randomized controlled trial
- gas chromatography
- systematic review
- open label
- electronic health record
- single cell
- neoadjuvant chemotherapy
- double blind
- big data
- squamous cell carcinoma
- newly diagnosed
- free survival
- mass spectrometry
- rectal cancer
- radiation therapy
- artificial intelligence
- deep learning
- high resolution